237 related articles for article (PubMed ID: 28803996)
1. Perioperative hemodynamics and outcomes of patients on metyrosine undergoing resection of pheochromocytoma or paraganglioma.
Butz JJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; McKenzie TJ; Schroeder DR; Martin DP; Sprung J
Int J Surg; 2017 Oct; 46():1-6. PubMed ID: 28803996
[TBL] [Abstract][Full Text] [Related]
2. Preoperative Metyrosine Improves Cardiovascular Outcomes for Patients Undergoing Surgery for Pheochromocytoma and Paraganglioma.
Wachtel H; Kennedy EH; Zaheer S; Bartlett EK; Fishbein L; Roses RE; Fraker DL; Cohen DL
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S646-54. PubMed ID: 26374407
[TBL] [Abstract][Full Text] [Related]
3. Preoperative Levels of Catecholamines and Metanephrines and Intraoperative Hemodynamics of Patients Undergoing Pheochromocytoma and Paraganglioma Resection.
Weingarten TN; Welch TL; Moore TL; Walters GF; Whipple JL; Cavalcante A; Bancos I; Young WF; Gruber LM; Shah MZ; McKenzie TJ; Schroeder DR; Sprung J
Urology; 2017 Feb; 100():131-138. PubMed ID: 27769919
[TBL] [Abstract][Full Text] [Related]
4. Metyrosine and pheochromocytoma.
Steinsapir J; Carr AA; Prisant LM; Bransome ED
Arch Intern Med; 1997 Apr; 157(8):901-6. PubMed ID: 9129550
[TBL] [Abstract][Full Text] [Related]
5. The combination of doxazosin and metyrosine as a preoperative treatment for pheochromocytomas and paragangliomas.
Ohmachi Y; Yamamoto M; Inaba Y; Makino S; Urai S; Matsumoto R; Bando H; Kanie K; Tsujimoto Y; Motomura Y; Sasaki Y; Oi-Yo Y; Yamamoto N; Suzuki M; Takahashi M; Iguchi G; Kanzawa M; Furukawa J; Shigemura K; Mizobuchi S; Ogawa W; Fukuoka H
Endocrine; 2024 May; 84(2):694-703. PubMed ID: 38206436
[TBL] [Abstract][Full Text] [Related]
6. Prospective study to compare peri-operative hemodynamic alterations following preparation for pheochromocytoma surgery by phenoxybenzamine or prazosin.
Agrawal R; Mishra SK; Bhatia E; Mishra A; Chand G; Agarwal G; Agarwal A; Verma AK
World J Surg; 2014 Mar; 38(3):716-23. PubMed ID: 24233658
[TBL] [Abstract][Full Text] [Related]
7. Surgical management of pheochromocytoma with the use of metyrosine.
Perry RR; Keiser HR; Norton JA; Wall RT; Robertson CN; Travis W; Pass HI; Walther MM; Linehan WM
Ann Surg; 1990 Nov; 212(5):621-8. PubMed ID: 1978640
[TBL] [Abstract][Full Text] [Related]
8. Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma.
Yao Y; Guo Y; Fan J; Lin T; Wang L; Zhang S
Front Endocrinol (Lausanne); 2023; 14():1139015. PubMed ID: 37152936
[TBL] [Abstract][Full Text] [Related]
9. Surgical outcome of laparoscopic surgery, including laparoendoscopic single-site surgery, for retroperitoneal paraganglioma compared with adrenal pheochromocytoma.
Hattori S; Miyajima A; Hirasawa Y; Kikuchi E; Kurihara I; Miyashita K; Shibata H; Nakagawa K; Oya M
J Endourol; 2014 Jun; 28(6):686-92. PubMed ID: 24499341
[TBL] [Abstract][Full Text] [Related]
10. Perioperative outcomes of syndromic paraganglioma and pheochromocytoma resection in patients with von Hippel-Lindau disease, multiple endocrine neoplasia type 2, or neurofibromatosis type 1.
Butz JJ; Yan Q; McKenzie TJ; Weingarten TN; Cavalcante AN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
Surgery; 2017 Dec; 162(6):1259-1269. PubMed ID: 28919049
[TBL] [Abstract][Full Text] [Related]
11. Surgical and Hemodynamic Outcomes in Pheochromocytoma Surgery: A Prospective Cohort Study.
Rao N; Ramachandran R; Tandon N; Singh P; Kumar R
Urology; 2016 Dec; 98():103-106. PubMed ID: 27639794
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic instability during percutaneous ablation of extra-adrenal metastases of pheochromocytoma and paragangliomas: a case series.
Deljou A; Kohlenberg JD; Weingarten TN; Bancos I; Young WF; Schroeder DR; Martin DP; Sprung J
BMC Anesthesiol; 2018 Nov; 18(1):158. PubMed ID: 30400849
[TBL] [Abstract][Full Text] [Related]
13. Laparoscopic Surgery for Pheochromocytoma and Paraganglioma Removal: A Retrospective Analysis of Anaesthetic Management.
Ramachandran R; Rewari V; Sharma A; Kumar R; Trikha A
Curr Hypertens Rev; 2016; 12(3):222-227. PubMed ID: 27160411
[TBL] [Abstract][Full Text] [Related]
14. Selective Versus Non-selective α-Blockade Prior to Laparoscopic Adrenalectomy for Pheochromocytoma.
Randle RW; Balentine CJ; Pitt SC; Schneider DF; Sippel RS
Ann Surg Oncol; 2017 Jan; 24(1):244-250. PubMed ID: 27561909
[TBL] [Abstract][Full Text] [Related]
15. Preoperative intravenous rehydration for patients with pheochromocytomas and paragangliomas: is it necessary? A propensity score matching analysis.
Kong H; Yang JN; Tian J; Li N; Zhang YX; Ye PC; Li XY; Zhang Z
BMC Anesthesiol; 2020 Nov; 20(1):294. PubMed ID: 33250060
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic Stability During Pheochromocytoma Resection: Lessons Learned Over the Last Two Decades.
Livingstone M; Duttchen K; Thompson J; Sunderani Z; Hawboldt G; Sarah Rose M; Pasieka J
Ann Surg Oncol; 2015 Dec; 22(13):4175-80. PubMed ID: 25822781
[TBL] [Abstract][Full Text] [Related]
17. Predictors of prolonged hypotension requiring vasopressor support after resection of pheochromocytoma and paraganglioma.
Shu Q; Lan L; Zhang Y; Yu C; Huang Y
Clin Endocrinol (Oxf); 2021 Dec; 95(6):841-848. PubMed ID: 34160851
[TBL] [Abstract][Full Text] [Related]
18. Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection.
Kinney MA; Warner ME; vanHeerden JA; Horlocker TT; Young WF; Schroeder DR; Maxson PM; Warner MA
Anesth Analg; 2000 Nov; 91(5):1118-23. PubMed ID: 11049893
[TBL] [Abstract][Full Text] [Related]
19. Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China.
Yang Y; Zhang J; Fang L; Jia X; Zhang W
Drug Des Devel Ther; 2022; 16():3599-3608. PubMed ID: 36262769
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of α-Blockers on Hemodynamic Control during Pheochromocytoma Resection: A Randomized Controlled Trial.
Buitenwerf E; Osinga TE; Timmers HJLM; Lenders JWM; Feelders RA; Eekhoff EMW; Haak HR; Corssmit EPM; Bisschop PHLT; Valk GD; Veldman RG; Dullaart RPF; Links TP; Voogd MF; Wietasch GJKG; Kerstens MN
J Clin Endocrinol Metab; 2020 Jul; 105(7):2381-91. PubMed ID: 31714582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]